Pharm Exam 1

0.0(0)
studied byStudied by 0 people
full-widthCall with Kai
full-widthOpen Podcast
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/221

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

222 Terms

1
New cards

Graded dose-response curve

a graph of increasing response to increasing drug concentration or dose

- 1 patient

<p>a graph of increasing response to increasing drug concentration or dose</p><p>- 1 patient</p>
2
New cards

potency

the strength of a drug

- more potent = less dosage

- determined by affinity for its receptor and/or ability of the drug to reach its site of action

3
New cards

efficacy

the ability to produce a desired or intended result

determined by:

- type of interaction with the receptor (agonist vs antagonist)

- limitations on amount that can be administered

POTENCY DOES NOT EQUAL MAXIMUM EFFICACY

<p>the ability to produce a desired or intended result</p><p>determined by:</p><p>- type of interaction with the receptor (agonist vs antagonist)</p><p>- limitations on amount that can be administered</p><p>POTENCY DOES NOT EQUAL MAXIMUM EFFICACY</p>
4
New cards

Emax

Maximum effect achievable by a drug

<p>Maximum effect achievable by a drug</p>
5
New cards

quantal dose response curve

represents dose response relationships in POPULATIONS

- Y-axis with end in "ing"

- represents variations in drug responses

6
New cards

hyporeactive

the intensity of a given dose of a drug is less than anticipated.

7
New cards

hyperreactive

intensity of a given dose of drug is greater than anticipated

8
New cards

tolerance

Time-related loss of response to a drug

- within weeks to months of being on a drug

9
New cards

idiosyncratic drug response

infrequently observed drug effect

10
New cards

tachyphylaxis

rapid decrease in response to a drug

- within minutes to hours of being on a drug

11
New cards

hypersensitivity

allergic reaction to a drug

12
New cards

therapeutic index

TD50/ED50 = TI

- indicator of a drug's safety

- greater the value of TI, the safer the drug is considered to be

- larger the TI, the larger the dose to evoke a toxic response

13
New cards

when the benefits outweigh the risks (cancer)

When is it acceptable to take a drug with a low TI?

14
New cards

Pharmacokinetics

Study of drug absorption, distribution, metabolism, and excretion.

15
New cards

bioavailability

The extent to which the drug reaches systemic circulation

- Through IV = 100%

- Orally, first pass effect

16
New cards

volume of distribution

body space into which a drug can diffuse

17
New cards

clearance

amount of blood from which all of a drug is removed per unit of time

18
New cards

half life

predicts how long it takes the dosing regimen to achieve steady-state concentrations

- 4-5 half lives

19
New cards

pharmacodynamics

study of a drug at the site of action and the EFFECT ON THE BODY

20
New cards

affinity

refers to the attraction between a receptor and a ligand (drug)

21
New cards

efficacy

____ refers to the ability of a ligand to bind to the receptor, activate it, and lead to some physiological response

22
New cards

agonist

a drug that binds to the receptor and causes some type of response

- has both affinity and efficacy

23
New cards

antagonist

a drug that binds to the receptor without resulting in any response

- only has affinity

24
New cards

selectivity

Drug elicits only the response for which it is given

- no such thing because of side effects

25
New cards

first pass effect

a phenomenon in which drugs given orally are carried directly to the liver after absorption, where they may be largely inactivated by liver enzymes before they can enter the general circulation; oral drugs frequently are given in higher doses than drugs given by other routes because of this early breakdown

- 50% is active

26
New cards

ED50

median effective dose:

- dose at which 50% of population responds in specified manner

27
New cards

TD50

median toxic dose

- dose at which 50% of the population exhibits adverse effect

28
New cards

no (high abuse: LSD, heroin)

are schedule I drugs used medically?

29
New cards

IV

Schedule II-___ drugs are used medically but also have the potential for abuse

30
New cards

aspirin uses

- analgesic

- antipyretic

- anti-inflammatory

- anti-platelet

31
New cards

blood thinner

the advantage of aspirin having antiplatelet qualities is that it can act as a ____ ____ and reduce the risk of heart attack, however, it increases the risk of hemorrhage

32
New cards

aspirin

Irreversible inhibitor of COX

- effects persist until new COX generated

33
New cards

doan's

Magnesium Salicylate (NSAID)

- relieve's musculoskeletal pain and inflammation

34
New cards

ben-gay

topical salicylate

- external use for pain and inflammation

- think icy hot

35
New cards

inhibition of COX

these drugs all have a MOA of _____ ___ ____

- ibuprofen

- naproxen

- fenoprofen

- piroxicam

- indomethacin

36
New cards

ibuprofen

shorter duration of action than naproxen

- anti-inflammatory

- anti-pyretic

- analgesic

- safe to use with anticoagulants

37
New cards

naproxen

has a long half life so administered less frequently

- anti-inflammatory

- antipyretic

- analgesic

- decreases renal blood flow

- shows an increase in liver toxicity in marathon runners

38
New cards

fenoprofen

less intense GI side effects than those occurring with aspirin

- reversible inhibitor of COX

- anti-inflammatory

- antipyretic

- analgesic

- good for mild/moderate pain (cramps, dental pain, headaches)

- good for OA and RA

39
New cards

piroxicam

once a day dosing (half life= 50-60 hours)

- used for OA and RA- 9.5x higher risk for peptic ulcer and bleeding compared to other NSAIDS

- antiplatelet: more similar to aspirin

40
New cards

indomethacin

used for arthritis, bursitis, gouty arthritis, close DA in premies

- reduces pain and fever but not used for these effects

- antiplatelet effects

- high incidence of dose-related side effects (25-50%)

- INITIAL TREATMENT OF GOUT AND MOST OFTEN USED TODAY FOR GOUT

41
New cards

celecoxib

used for OA and RA

- NO platelet aggregation

- anti-inflammatory

- antipyretic

- analgesic

- works on COX-2 and not on COX-1, so leaves protective prostaglandins in stomach

- fewer GI ulcers than other NSAIDS

- may increase risk for serious CV events (MI/stroke)

42
New cards

acetaminophen

only inhibits prostaglandins in CNS

- weak inhibition of COX

- analgesic

- antipyretic

- NOT an anti-inflammatory agent

- categorized as an analgesic

-used in fever reduction in children

-liver toxicity is most serious side effect

43
New cards

methotrexate

- rapid acting DMARD (3-6 weeks)

- this is the drug given initially to treat, other agents if not working

44
New cards

sulfasalazine

treats IBD

- retards progression of joint deterioration

- GI problems and rash

- may produce serious hypersensitivity and blood dyscrasias

45
New cards

leflunomide

suppresses immune cell proliferation (reduces inflammation)

- slows formation of bone erosion

- well tolerated, benefits in 1 month

- side effects: GI distress, rash, liver function

46
New cards

etanercept

anti tumor necrosis factor (TNF) drug

- biologic

- injection under the skin weekly

- increased risk of infection especially if used with other immunosuppressants

- prevents release of cytokines (role in immune response and inflammation)

47
New cards

adalimumab

- biologic

- anti TNF alpha drug

- injection under the skin weekly or bi-weekly

- increased risk of infection especially if used with other immunosuppressants

48
New cards

Tofacitinib

- janus kinase inhibitor (which play a role in joint inflammation)

- possibly inhibits progression of structural damage

49
New cards

colchicine

- prophylaxis of recurrent episodes of gouty arthritis

- troublesome diarrhea

- grapefruit can elevate levels

50
New cards

probenecid

- decreases net reabsorption of uric acid by affecting transport sites

- large urine volume recommended to minimize possibility of kidney stones

51
New cards

allopurinol

- xanthine oxidase inhibitor

- long-term treatment to prevent gout attacks

- not used to treat acute gout attacks

52
New cards

morphine

- mu agonist

- does not reach the brain quickly, lasts 4-5 hours

- relieves pain

- side effects: orthostatic hypotension, constipation, pupil constriction, respiratory depression

53
New cards

Hydromorphone

- mu agonist

- more lipid soluble, able to cross BBB more rapidly, faster acting

- relieves severe pain, extended release capsules exist

- constipation and dizziness can occur

54
New cards

codeine

- mild to moderate pain reliever (never achieves morphine-like efficacy)

- often used in combination with aspirin or acetaminophen

55
New cards

oxycodone

- never achieves morphine-like efficacy

- schedule II drug (VERY addictive)

- Purdue Pharma scandal

56
New cards

methadone

- mu agonist

- equipotent with morphine

- longer duration of action

- used in treatment of opioid abuse (milder withdrawal symptoms, helps taper them off)

57
New cards

fentanyl

- mu agonist

- most widely used of synthetic opioids (legally and illegally)

- 100x more potent than morphine

- short acting (1-1.5 hours)

58
New cards

tramadol

- weak mu agonist

- mild to moderate pain

- may cause seizures (never give to epileptics)

- useful in chronic neuropathic pain

59
New cards

naloxone

- aka narcan

- mu antagonist

- used to treat opioid overdoses

60
New cards

naltrexone

- useful in treatment of alcoholism (blocks endogenous opioids that give feeling of euphoria)

61
New cards

cromolyn sodium

- stabilizes mast cells and prevents release of contents

- takes 2-3 weeks to be effective

- aerosol and nasal spray

- side effects: burning, itching, sneezing, coughing

62
New cards

H1 blockers

- classical type

- allergies

- first generation (drowsiness)

- second generation (non-sedating)

63
New cards

H2 blockers

inhibits gastric acid secretion

- relieves symptoms of ulcers

64
New cards

diphenhydramine

- first generation

- H1 blocker

- for allergies

- sedation in 50% of patients

65
New cards

dimenhydrinate

- aka dramamine

- H1 blocker

- 1st generation

- causes muscular weakness/drowsiness

66
New cards

fexofenadine

- 2nd generation

- H1 blocker

- for allergies

- causes less drowsiness

67
New cards

loratadine

- 2nd generation

- H1 blocker

- for allergies, less sedating

- once a day extended release formulas

68
New cards

cimetidine

- H2 blocker

- inhibits cytochrome p450 metabolism of other drugs

- causes headaches, breast tissue in males

69
New cards

famotidine

- H2 blocker

- heart burn and gastric acid relief

70
New cards

glucocorticoids

- influence carbohydrate metabolism

71
New cards

mineralcorticoids

- modulate salt and water balance

72
New cards

cortisol

____ is the most important endogenous glucocorticoid

73
New cards

ACTH

the synthesis of glucocorticoids is controlled by ____

74
New cards

aldosterone

____ is the most important endogenous mineralcorticoid

75
New cards

RAAS (renin-angiotensin-aldosterone system)

mineralcorticoids are regulated by the ____

76
New cards

hydrocortisone

- similar to cortisol

- also has mineralcorticoid properties

- replacement therapy

- also to treat allergic reactions, inflammation, cancer

- at low doses, generally safe

77
New cards

fludrocortisone

- mineralcorticoid available for replacement therapy

- also glucocorticoid activity

- treats Addison's disease, hypoaldosteronism, and congenital adrenal hyperplasia

- if dose is too high, salt and water retention= weight gain, HTN, hypokalemia, and edema

78
New cards

withdraw

you should never _____ someone abruptly from a corticosteroid as it is life-threatening

- may need to taper from 2 months-1 year

- need to allow recovery of normal pituitary-adrenal response to endogenous corticosteroids

79
New cards

false

T/F: corticosteroids decrease blood glucose levels

80
New cards

cortisone

- an inactive form of cortisol, or a synthetic, anti-inflammatory medication used in medical treatments

81
New cards

PSNS

Housekeeping (GI, bladder, eye)

- slows HR

- increased gastric secretion

- emptying of bladder

- emptying of bowel

- focusing of the eye for near vision

- constriction of pupil

- contraction of bronchial smooth muscle

82
New cards

SNS

Fight or flight

- increased HR and BP

- shunting of blood away from skin to muscles

- dilation of bronchi

- dilation of pupils

- mobilization of stored energy

83
New cards

Ach

what NT is binds to cholinergic receptors?

- Nicotinic N/M and muscarinic

84
New cards

NE and Epi

What NTs bind to adrenergic receptors

- Alpha 1/2, Beta 1/2/3, and dopamine

85
New cards

heart

Beta1 is dominate in the ____

86
New cards

lung

beta2 is dominate in the ____

87
New cards

life cycle of Ach

choline + acetylcoenzyme A

- stored

- destroyed by AchE

- uptake of choline

88
New cards

life cycle of NE

- precursors

- stored in vesicles

- reuptake

- converted to Epi

89
New cards

bethanechol

- muscarinic agonist

- relieves urinary retention

90
New cards

atropine

- muscarinic antagonist

- used for muscarinic poisoning

91
New cards

physostigmine

- inhibitor of AchE

- given for antimuscarinic poisoning (atropine poisoning)

92
New cards

neostigmine

- reversible cholinesterase inhibitor

- used for myasthenia gravis

- binds to cholinesterase preventing it from catalyzing breakdown of Ach

93
New cards

tubocurarine

- neuromuscular blocking agent (non-depolarizing)

- competes with Ach to bind to nicotinicM receptors

- Uses: muscle relaxation during surgery, mechanical ventilation, endotracheal intubation, and electroconvulsive therapy

94
New cards

succinylcholine

- neuromuscular blocking agent (depolarizing)

- binds to nicotinicM receptors and remains bound resulting in constant depolarization

- uses: endotracheal intubation, electroconvulsive therapy, endoscopy

95
New cards

epinephrine

- catecholamine (adrenergic agonist)

- alpha1, alpha2, beta1, beta2

- anaphylactic shock, delay absorption of anesthetics, hemostasis, reduce nasal congestion, overcome AV heart block, pupil dilation, asthma

96
New cards

norepinephrine

- catecholamine (adrenergic agonist)

- alpha1, alpha2, beta1

- used for hypotension and cardiac arrest

97
New cards

isoproterenol

- catecholamine (adrenergic agonist)

- beta1, beta2

- uses: AV heart block, asthma, bronchospasm

98
New cards

dopamine

- catecholamine (adrenergic agonist)

- dopamine, beta1, alpha1

- uses: shock, heart failure, acute renal failure

99
New cards

terbutaline

- noncatecholamine

- beta2

- uses: asthma and preterm labor

100
New cards

ephedrine

- noncatecholamine

- alpha1, alpha2, beta1, beta2

- uses: nasal congestion and narcolepsy